Psychiatry & Neurology Doctors in Berlin, NH Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Beatrice Claudia Engstrand, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 59 Page Hill Rd, Berlin, NH 03570 Phone: 603-752-2200    Fax: 603-752-6474

Dr. Crizeldo De Guzman Cariaso, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 59 Page Hill Rd, Berlin, NH 03570 Phone: 603-752-2200

Dr. Garrett V Graves, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3 12th St, Berlin, NH 03570 Phone: 603-752-7404    Fax: 603-752-5194

Stacey Charron, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3 12th St, Berlin, NH 03570 Phone: 603-752-7404    Fax: 603-752-5194

Dr. Erinn Lynne Fellner, M.D. Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 3 12th St, Berlin, NH 03570 Phone: 603-752-7404    Fax: 603-752-5194

News Archive

GOG to conduct Phase II trial on primary peritoneal cancer

Oncolytics Biotech Inc. announced today that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN(R) in patients with persistent or recurrent, ovarian, fallopian tube or primary peritoneal cancer (GOG186H).

Lancet examines WHO Euro Health 2020 initiative

The Lancet examines Health 2020, "a 'process of consultation' between WHO Euro and its 53 diverse member states" that "will build partnerships to tackle the complex determinants and drivers of health and health equity."

BUYINS.NET updates coverage on MedeFile International

BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on MedeFile International after releasing the latest short sale data through May 27, 2010. The total aggregate number of shares shorted since August 2009 is approximately 1.75 billion shares.

New range prediction approach increases accuracy, safety and tolerability of proton therapy

Today (Tuesday, 23 April) marks the beginning of a new era in treatment planning at the University Proton Therapy Dresden of the University Hospital in Dresden (Germany): For the worldwide first time, a new approach increases the accuracy, safety and probably also the tolerability of proton therapy.

Post-pandemic lockdown has changed the attitudes of New Zealanders, shows study

In the first few weeks of the lockdown of New Zealand in response to the COVID-19 pandemic, residents reported a slight increase in mental distress but higher levels of confidence in the government, science and the police, as well as greater patriotism, according to research published by the American Psychological Association.

Read more Medical News

› Verified 5 days ago